TacticScale

What Cabot Does & How It Makes Money (CBT)

Updated October 2026 · reflects Cabot's latest reported financials

Specialty chemicals maker of carbon black, fumed silica and battery materials. Cabot earns revenue by selling reinforcing carbons, specialty carbons, fumed metal oxides, aerogel, masterbatches and other performance materials to tire, industrial, battery and consumer-product manufacturers.

Cabot's story, moat and numbers — in a 3-minute visual book.

Explore Cabot on TacticScale →

How Cabot makes money

Cabot earns revenue by selling reinforcing carbons, specialty carbons, fumed metal oxides, aerogel, masterbatches and other performance materials to tire, industrial, battery and consumer-product manufacturers. It sells through distributors and sales representatives across the Americas, EMEA and Asia Pacific.

What Cabot does

Cabot Corporation is a Boston-based specialty chemicals and performance materials company founded in 1882. It has two segments. Reinforcement Materials supplies reinforcing carbons that strengthen rubber in tires and in industrial goods such as hoses, belts and molded parts, along with engineered elastomer composites. Performance Chemicals covers specialty carbons for inks, coatings, plastics, toners and displays; fumed silica and fumed alumina; aerogel for thermal insulation; masterbatch and conductive compounds; and inkjet colorants. A growing part of the business is battery materials. Cabot supplies conductive additives, carbon nanotubes and fumed alumina for lead-acid and lithium-ion batteries, including those used in electric vehicles. Customers span automotive, industrial, packaging, infrastructure, agriculture, consumer products and electronics. Sales go through distributors and sales representatives worldwide.

Products & services

What is Cabot worth?

On an owner-earnings DCF, Cabot's most-likely value is about $68 versus a recent price near $75 (10% above fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$48) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.

Verdict: Fairly priced — no edge
Owner-earnings fair value · recent price ≈ $75
Fair value (most likely)
$68
Range
$58–$86
No-growth floor
$48
Price
~$75

Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.

Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →

Sector Basic Materials Industry Specialty Chemicals HQ United States Ticker CBT Official site

Related companies

Albemarle (ALB) · Camel (601311.SS) · Shenzhen Capchem Technology (300037.SZ) · Shijiazhuang Shangtai Technology (001301.SZ) · Cathay Biotech (688065.SS)